FDA Grants Orphan Drug Designation for Treatment of Pancreatic Neuroendocrine Tumors
Surufatinib was recently granted Orphan Drug designation by the FDA. This drug was made for the treatment of pancreatic neuroendocrine tumors (PanNETs). It was created by Hutchison China MediTech…